Dabi-SNAP trial
Patients already receiving dabigatran are excluded partly to avoid potential harm from switching them to an FXa inhibitor if dabigatran is beneficial. Dabi-SNAP is a nested domain within the SNAP adaptive platform trial. The trial enrolls…
1 sources - 5 claims
Patients already receiving dabigatran are excluded partly to avoid potential harm from switching them to an FXa inhibitor if dabigatran is beneficial. Dabi-SNAP is a nested domain within the SNAP adaptive platform trial. The trial enrolls adults already enrolled in SNAP who are taking or imminently starting an oral FXa inhibitor for an approved indication.